Metabolomics for mitochondrial and cancer studies

Biochimica Et Biophysica Acta
Deepak NagrathNadège Bellance

Abstract

Metabolomics, a high-throughput global metabolite analysis, is a burgeoning field, and in recent times has shown substantial evidence to support its emerging role in cancer diagnosis, cancer recurrence, and prognosis, as well as its impact in identifying novel cancer biomarkers and developing cancer therapeutics. Newly evolving advances in disease diagnostics and therapy will further facilitate future growth in the field of metabolomics, especially in cancer, where there is a dire need for sensitive and more affordable diagnostic tools and an urgency to develop effective therapies and identify reliable biomarkers to predict accurately the response to a therapy. Here, we review the application of metabolomics in cancer and mitochondrial studies and its role in enabling the understanding of altered metabolism and malignant transformation during cancer growth and metastasis. The recent developments in the area of metabolic flux analysis may help to close the gap between clinical metabolomics research and the development of cancer metabolome. In the era of personalized medicine with more and more patient specific targeted therapies being used, we need reliable, dynamic, faster, and yet sensitive biomarkers both to track the disease...Continue Reading

References

Aug 15, 2012·Journal of Bioenergetics and Biomembranes·Hsiu-Chuan Chou, Hong-Lin Chan
Mar 14, 2012·PloS One·James R RoedeDean P Jones
Jun 27, 2014·Cell Death & Disease·Christine A CanebaDeepak Nagrath
Oct 6, 2015·Metabolites·Mahbuba Rahman, Mohammad Rubayet Hasan
Jan 26, 2016·International Journal of Cancer. Journal International Du Cancer·Daniela RodriguesMárcia Carvalho
Apr 23, 2016·European Journal of Preventive Cardiology·Anthony C DonaGemma Figtree
Jun 21, 2017·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Noa Godin, Jerry Eichler
Jun 19, 2014·The Analyst·Maria José Nunes de PaivaZenilda de Lourdes Cardeal
Dec 1, 2017·Metabolomics : Official Journal of the Metabolomic Society·Ray O Bahado-SinghKunle Odunsi
Jun 18, 2020·British Journal of Biomedical Science·R RashedF Zahran
Aug 17, 2012·American Journal of Physiology. Endocrinology and Metabolism·Christine A CanebaDeepak Nagrath
Jun 24, 2018·BMC Gastroenterology·R Taylor RipleyDavid S Schrump
Sep 10, 2019·Metallomics : Integrated Biometal Science·Luis GalvezGunda Koellensperger
May 13, 2017·International Journal of Molecular Medicine·Dimitris TsoukalasAristides M Tsatsakis
Jun 25, 2020·Metabolomics : Official Journal of the Metabolomic Society·Gunter van der Walt, Roan Louw

Citations

Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Daniel E StaffordGregory Stephanopoulos
Jun 25, 2002·Biophysical Journal·Daniel A BeardHong Qian
Nov 15, 2002·Biotechnology and Bioengineering·Christina ChanMartin L Yarmush
Apr 4, 2003·Biotechnology and Bioengineering·Anthony P Burgard, Costas D Maranas
Apr 5, 2003·Biotechnology Progress·Christina ChanGeorge Stephanopoulos
May 17, 2003·Metabolic Engineering·Christina ChanMartin L Yarmush
Nov 5, 2003·Biotechnology and Bioengineering·Anthony P BurgardCostas D Maranas
Jan 14, 2004·Genome Research·Anthony P BurgardCostas D Maranas
Apr 23, 2004·Journal of Lipid Research·Hyuntae YooJoanne K Kelleher
May 12, 2004·Journal of Theoretical Biology·Daniel A BeardHong Qian
Oct 23, 2004·International Journal of Cancer. Journal International Du Cancer·Kunle OdunsiJames L Alderfer
Nov 24, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jun YangQing Yang
Jun 15, 2005·Nature Reviews. Microbiology·Douglas B KellStephen G Oliver
Jun 24, 2006·Metabolic Engineering·Soumitra GhoshMichael M Domach
Nov 8, 2006·Metabolic Engineering·Maciek R AntoniewiczGregory Stephanopoulos
Dec 8, 2006·Bioinformatics·Andrea L KnorrRanjan Srivastava
Feb 24, 2007·Analytical Biochemistry·Tobias KindRobert H Weiss
Mar 30, 2007·Annals of Biomedical Engineering·Deepak NagrathMartin L Yarmush
Jul 17, 2007·Metabolic Engineering·Patrick F SuthersCostas D Maranas
Aug 19, 2007·Journal of Proteome Research·Aalim M WeljieFrank R Jirik
Sep 6, 2007·Drug Metabolism Reviews·Chi ChenJeffrey R Idle
Jan 26, 2008·BMC Bioinformatics·Erwin P GianchandaniJason A Papin
Mar 28, 2008·The Journal of Biological Chemistry·Hyuntae YooJoanne K Kelleher
Sep 24, 2008·In Vitro Cellular & Developmental Biology. Animal·Michelle HartmannJürgen Nolte
Nov 15, 2008·Molecular & Cellular Proteomics : MCP·Kyoungmi KimRobert H Weiss
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer L SpratlinS Gail Eckhardt
Jan 23, 2009·PloS One·Stefano TizianiUlrich L Günther
May 6, 2009·Reproductive Biology and Endocrinology : RB&E·Alberto RevelliPaolo Rinaudo
May 20, 2009·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Nicholas J ZyromskiDaniel Raftery
May 21, 2009·Experimental and Molecular Pathology·Andrew N LaneDonald M Miller
Jun 3, 2009·Biophysical Journal·Shakti GuptaShankar Subramaniam
Jun 11, 2009·Metabolic Engineering·Deepak NagrathMartin L Yarmush
Jul 2, 2009·Journal of Separation Science·Haleem J IssaqTimothy D Veenstra

Related Concepts

Metabolic Process, Cellular
Asparagine
Biochemical Pathway
Tryptophan
Carbohydrate nutrients
Urine
Bile Acid Measurement
glucose-1-phosphate
Xanthine
Glycerin

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Carolyn M SlupskyMichael B Sawyer
Journal of Molecular and Cellular Cardiology
Lisa C HeatherJulian L Griffin
American Journal of Physiology. Lung Cellular and Molecular Physiology
Paige Lacy
© 2020 Meta ULC. All rights reserved